welcome to cyprotex adme
welcome to cyprotex adme
cloe predict
cloe select
cloe screen

Cloe® Select

Bespoke ADME and DMPK experimental service

Our Cloe® Select ADME and DMPK experimental service is designed to meet the requirements of later stage studies. Services include: in vitro metabolism, in vitro permeability, in vitro protein binding and physicochemical properties and PK and bioanalysis. Cloe® Select offers the following benefits:

 

  • Flexibility - a portfolio of bespoke studies which can be customised to individual requirements.
  • Regulations - as with our Cloe® Screen ADME screens, our Cloe® Select service maintains and complies with regulatory guidelines providing constant confidence in the data received.
  • Results - a number of different reporting options are available from summary data to full written reports.
  • Consultancy - studies overseen by a single highly experienced and dedicated Principal Scientist who provides a high level of support and guidance prior to, during, and after the study.

 

Cloe® Select Services

In vitro metabolism
metabolite profiling and identification
cytochrome P450 induction
cytochrome P450 Ki
time dependent inhibition (kinact/KI )
UGT1A1 inhibition
In vitro permeability
P - glycoprotein inhibition
Bioanalysis
bioanalytical method development and validation
Physicochemical properties
pKa and log P determination
Protein binding
brain tissue binding
blood to plasma ratio

Additional services are available under Cloe® Screen

Can't see the assay you need?

Please contact our Product Development Team with your requirements.

request
Tell us what services you're interested in and we'll send you a quote.
request
spotlight on

Genomic ADME - gADME™

Cyprotex's proprietary gADME™ system can alert you to genetic variations in drug metabolism, allowing for personalised doses, drug rescue and repositioning.
Learn more about gADME

In vitro Micronucleus Test

Cyprotex now offers the in vitro micronucleus test for genotoxicity assessment using an automated, high content screening method for improved detection and reliability.
Learn more about our in vitro MNT service

Drug Transporters

Cyprotex provides a full range of drug-transporter studies as recommended by the ITC white paper and EMA guidelines.
Learn more about transporters

ADMET for Medicinal Chemists: A Practical Guide
ADMET for Medicinal Chemists: A Practical Guide
By Dr. Katya Tsaioun, Chief Scientific Officer, Cyprotex
Wiley & Sons, March 2011
Save 20%! Request your discount coupon.
request
careerscontactlegalprivacy
This website was last updated
on 3rd February 2012
This website is intended to assist investors, industry participants, customers and employees to understand Cyprotex’s global operations and ambitions.
Certain information and detail is disclosed in the interest of compliance of AIM Rule 26.